Published in Curr Opin Investig Drugs on December 01, 2007
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol (2009) 1.34
CXCL10 blockade protects mice from cyclophosphamide-induced cystitis. J Immune Based Ther Vaccines (2008) 1.04
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner. PLoS One (2012) 0.95
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model. Cancer Microenviron (2010) 0.95
Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo. Cell Immunol (2009) 0.93
The role of regulatory T cells in cancer. Immune Netw (2009) 0.93
SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines. Cancer Res (2014) 0.87
Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery. J Clin Immunol (2011) 0.85
SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines. Expert Rev Vaccines (2014) 0.85
Infiltrative T regulatory cells in enucleated uveal melanomas. Trans Am Ophthalmol Soc (2009) 0.82
Regulatory T cells in inflammatory bowel diseases and colorectal cancer. World J Gastroenterol (2012) 0.81
Increased P-35, EBI3 Transcripts and Other Treg Markers in Peripheral Blood Mononuclear Cells of Breast Cancer Patients with Different clinical Stages. Adv Pharm Bull (2015) 0.79
When Cells Suffocate: Autophagy in Cancer and Immune Cells under Low Oxygen. Int J Cell Biol (2011) 0.79
ProtEx technology for the generation of novel therapeutic cancer vaccines. Exp Mol Pathol (2009) 0.79
Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells. Exp Ther Med (2012) 0.79
4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression. PLoS One (2016) 0.78
Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors. Curr Pharm Biotechnol (2013) 0.78
Cancer vaccines: current directions and perspectives in prostate cancer. Curr Opin Mol Ther (2009) 0.78
Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model. Cell Mol Immunol (2012) 0.77
Modulatory role of regulatory T cells in a murine model of severe equine asthma. BMC Vet Res (2017) 0.75
Current perspectives in prostate cancer vaccines. Anticancer Agents Med Chem (2009) 0.75
Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines. Oncoimmunology (2013) 0.75
SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer. Oncoimmunology (2015) 0.75
Role of LAP(+)CD4(+) T cells in the tumor microenvironment of colorectal cancer. World J Gastroenterol (2017) 0.75
Anatomically corrected malposition of the great arteries {S, D, L} with left juxtaposition of the atrial appendages in DORV: influence on surgical approach. World J Pediatr Congenit Heart Surg (2013) 2.98
Anatomically corrected malposition. World J Pediatr Congenit Heart Surg (2013) 1.98
Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol (2009) 1.79
Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg (2002) 1.73
Epidemiological study of hypertension in natives of Spiti Valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study. J Assoc Physicians India (2012) 1.54
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol (2007) 1.48
CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model. J Immunol (2007) 1.48
Retrograde cerebral perfusion for brain protection in aortic aneurysm surgery. J Cardiovasc Med (Hagerstown) (2009) 1.38
Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation (2008) 1.38
Subcutaneous emphysema secondary to pulmonary cavity in absence of pneumothorax or pneumomediastinum. Respir Med (2006) 1.38
TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol (2011) 1.29
Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors. Cancer Res (2009) 1.26
Genetic counseling and prenatal diagnosis in India--experience at Sir Ganga Ram Hospital. Indian J Pediatr (2003) 1.25
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines. Cancer Res (2010) 1.21
Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity (2002) 1.19
Pancreatic islets under attack: cellular and molecular effectors. Curr Pharm Des (2007) 1.10
Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Res (2004) 1.10
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity. Vaccine (2009) 1.09
Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood (2004) 1.06
Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res (2014) 1.05
The improvement of care for paediatric and congenital cardiac disease across the World: a challenge for the World Society for Pediatric and Congenital Heart Surgery. Cardiol Young (2008) 1.04
SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ. PLoS One (2012) 0.99
Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein. J Immunol (2008) 0.97
Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation (2015) 0.96
Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother (2006) 0.95
Anomalous origin of the left coronary artery from the pulmonary artery with patent ductus arteriosus: a must to recognize entity. Eur J Echocardiogr (2010) 0.95
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner. PLoS One (2012) 0.95
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models. PLoS One (2013) 0.93
Surgical outcome of staged univentricular-type repairs for patients with univentricular physiology and pulmonary hypertension. Indian Heart J (2004) 0.91
Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase. J Immunol (2012) 0.90
A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model. Mol Immunol (2007) 0.90
Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol (2007) 0.89
Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection. Circulation (2003) 0.89
Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells (2007) 0.89
Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon. Exp Mol Pathol (2006) 0.88
Vasopressin in the pediatric cardiac intensive care unit: Myth or reality. Ann Pediatr Cardiol (2009) 0.88
Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+CD25+ Treg cells. Transplantation (2005) 0.87
Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J Autoimmun (2011) 0.86
Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice. Int Immunol (2006) 0.86
Transposition of great arteries with aortopulmonary window: an unusual cause of prepared left ventricle at 11 months. Indian Heart J (2005) 0.85
Is durable macrochimerism key to achieving clinical transplantation tolerance? Curr Opin Organ Transplant (2011) 0.85
Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin. Am J Respir Cell Mol Biol (2014) 0.85
Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis. Pediatr Res (2010) 0.85
Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice. J Immunol (2011) 0.85
SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines. Expert Rev Vaccines (2014) 0.85
Predominant expression of the Th2 response in chronic cardiac allograft rejection. Transpl Int (2003) 0.85
SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model. Vaccine (2010) 0.84
Redo mitral valve surgery-a long-term experience. J Card Surg (2004) 0.84
Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation. Am J Respir Cell Mol Biol (2013) 0.84
The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer. J Assist Reprod Genet (2012) 0.84
Juxtaductal coarctation with type B dissection of the aorta: a new operative technique. J Thorac Cardiovasc Surg (2002) 0.84
Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment. Stem Cells (2010) 0.83
Sustainable effect of Ayurvedic formulations in the treatment of nutritional anemia in adolescent students. J Altern Complement Med (2010) 0.83
Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo. Hum Gene Ther (2006) 0.82
Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity. Chem Biol Drug Des (2014) 0.82
Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells (2007) 0.82
Total anomalous pulmonary venous connection: helical computed tomography as an alternative to angiography. Indian Heart J (2004) 0.81
The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation. Bioessays (2006) 0.81
Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride. Pak J Pharm Sci (2013) 0.81
Epidemiological study of chronic mountain sickness in natives of Spiti Valley in the Greater Himalayas. High Alt Med Biol (2013) 0.81
Genetic admixture of European FRDA genes is the cause of Friedreich ataxia in the Mexican population. Genomics (2004) 0.81
A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity. Cancer Res (2003) 0.81
Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells. Transpl Immunol (2003) 0.81
Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice. PLoS One (2011) 0.80
Structural evaluation of radially expandable cardiovascular stents encased in a polyurethane film. J Biomed Mater Res B Appl Biomater (2006) 0.80
Active epilepsy as indicator of neurocysticercosis in rural northwest India. Epilepsy Res Treat (2012) 0.80
Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation. Int Immunol (2013) 0.79
ProtEx technology for the generation of novel therapeutic cancer vaccines. Exp Mol Pathol (2009) 0.79
Therapeutic applications of vasopressin in pediatric patients. Indian Pediatr (2012) 0.79
Occult anomalous origin of the left coronary artery from the pulmonary artery with ventricular septal defect. Ann Pediatr Cardiol (2011) 0.79